Lam Research (NASDAQ:LRCX) Price Target Raised to $150.00 at Rothschild & Co Redburn

Lam Research (NASDAQ:LRCX) had its price target hoisted by Rothschild & Co Redburn from $140.00 to $150.00 in a research note issued to investors on Tuesday,MarketScreener reports. The brokerage currently has a buy rating on the semiconductor company’s stock.

Other research analysts also recently issued research reports about the company. HSBC set a $127.00 price objective on Lam Research and gave the stock a “hold” rating in a research note on Tuesday, September 30th. Erste Group Bank started coverage on Lam Research in a research note on Thursday, August 14th. They issued a “buy” rating on the stock. Barclays set a $83.00 price objective on Lam Research and gave the stock an “equal weight” rating in a research note on Monday, July 28th. B. Riley raised their price objective on Lam Research from $130.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, September 24th. Finally, UBS Group raised their price objective on Lam Research from $95.00 to $120.00 and gave the stock a “buy” rating in a research note on Monday, July 21st. Twenty-three investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $123.80.

Lam Research Stock Up 0.4%

LRCX stock opened at $138.31 on Tuesday. Lam Research has a fifty-two week low of $56.32 and a fifty-two week high of $153.70. The business’s 50-day moving average is $116.42 and its two-hundred day moving average is $95.48. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.55 and a current ratio of 2.21. The company has a market cap of $174.41 billion, a price-to-earnings ratio of 33.25, a P/E/G ratio of 1.67 and a beta of 1.84.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.12. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The company had revenue of $5.17 billion for the quarter, compared to the consensus estimate of $4.99 billion. During the same quarter in the prior year, the company earned $1.03 earnings per share. Lam Research’s revenue was up 33.6% on a year-over-year basis. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. As a group, analysts forecast that Lam Research will post 3.71 earnings per share for the current year.

Lam Research Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th will be paid a dividend of $0.26 per share. This is a boost from Lam Research’s previous quarterly dividend of $0.23. The ex-dividend date of this dividend is Wednesday, September 24th. This represents a $1.04 annualized dividend and a yield of 0.8%. Lam Research’s dividend payout ratio is 25.00%.

Insiders Place Their Bets

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the transaction, the senior vice president owned 251,047 shares in the company, valued at $34,870,428.30. This trade represents a 17.21% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.31% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Lam Research

Institutional investors have recently added to or reduced their stakes in the company. Smallwood Wealth Investment Management LLC purchased a new position in Lam Research during the 1st quarter valued at approximately $26,000. IMG Wealth Management Inc. purchased a new position in Lam Research during the 2nd quarter valued at approximately $26,000. Howard Hughes Medical Institute purchased a new position in Lam Research during the 2nd quarter valued at approximately $27,000. Strategic Wealth Investment Group LLC purchased a new position in Lam Research during the 2nd quarter valued at approximately $29,000. Finally, Delos Wealth Advisors LLC purchased a new position in shares of Lam Research in the 2nd quarter worth approximately $30,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.